Term ends Jul 17, 2028 · High confidence
20-year base term ended Sep 25, 2026
Held by Catalyst Biosciences, Inc.
Filed Dec 17, 2007 as application 11/958,353 · Granted Jul 1, 2014
Base term plus 661 days of patent term adjustment (USPTO delay)
Today
2006
2028
Clock starts
Sep 25, 2006
Sep 25, 2006
Term ends
Jul 17, 2028
Jul 17, 2028
Granted
Jul 1, 2014
Jul 1, 2014
base term
patent term adjustment
fee events
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
661
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
2
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 661 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Sep 25, 2006, when application PCT/CN2006/002504, the earliest non-provisional in its chain, was filed (this one was filed Dec 17, 2007) | Sep 25, 2026 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +661 days, USPTO patent term adjustment record | Jul 17, 2028 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Jul 17, 2028 | High confidence |
This family
| US 8,765,726 | this patent Jul 2028 | Jul 2028 |
1 of 2 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Mar 17, 2008 Reel 20659, frame 280 | Wu, Jun; Luo, Ying; Zhou, Tieling | Shanghai Genomics, Inc. | Assignment of Assignor's Interest |
| May 7, 2020 Reel 52598, frame 873 | Shanghai Genomics, Inc. | Gni Hong Kong Limited | Assignment of Assignor's Interest |
| Apr 10, 2023 Reel 63270, frame 913 | Gni Hong Kong Limited | Catalyst Biosciences, Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Jul 2028
Term ends Jul 17, 2028. No further fees fall due before then
Note
The 661 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
15
later US patents cite this one
That is above the median of utility patents granted in 2014 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.